The Israeli pharma firm said that fremanezumab showed statistically significant and clinically meaningful results in the phase 3 studies in chronic (CM) and episodic migraine (EM). It added
The approval has been granted for cemiplimab to treat adults with metastatic CSCC and adults with locally advanced and unresectable CSCC. CSCC is claimed to be the second
The company also revealed that it will be shuttering its Bridgewater research and development office in New Jersey along with the Lilly China Research and Development Center in
The drug showed a statistically-significant improvement in lung function in patients with moderate to very severe stable COPD compared against individual component that included either aclidinium bromide or formoterol.
The settlement with the US federal government is for resolving claims that the Danish multinational pharma failed to comply with the US Food and Drug Administration (FDA)-mandated Risk
Alecensa has significantly decreased the risk of disease deterioration or death (progression-free survival, PFS) by 85% compared against chemotherapy in patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small
Keytruda has been approved as a monotherapy to treat locally advanced or metastatic urothelial carcinoma in adults who have received prior platinum-containing chemotherapy and adults who are not
The Swiss pharma major has reported positive topline results from the study, which assessed the safety and efficacy of oral once-daily fingolimod in children and adolescents (ages 10 to
The deal will also see the Canadian firm sell certain rights to plasma products and technology to the joint venture pertained to the Chinese market. The acquisition will
The approval will allow Pfizer to treat adults and children two years and older with relapsed or refractory CD33-positive AML with Mylotarg. Mylotarg is an antibody-drug conjugate that
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.